A Phase III Multicenter, Double-Blind, Parallel-Group, Placebo Controlled Study to Measure the Effect of Riluzole 50 mg b.i.d. Over a Period of Three Years on the Progression of Huntington's Disease A Phase III Multicenter, Double-Blind, Parallel-Group, Placebo Controlled Study to Measure the Effec ...